Retroviral transfer of a dominant TCR prevents surface expression of a large proportion of the endogenous TCR repertoire in human T cells

Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes

Richard A. Morgan, Mark E. Dudley, John R. Wunderlich et al. · Science · 2006 · 2.6K citations · Full text

Medicine, Immunology, Oncology +14

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.

R J Murray, Michael G. Kurilla, Jill Brooks et al. · The Journal of Experimental Medicine · 1992 · 506 citations · Full text

Life Sciences, Immunology, Oncology +17

Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state

Rosemary J. Tierney, Neil Steven, Lawrence S. Young et al. · Journal of Virology · 1994 · 492 citations · Full text

Life Sciences, Microbiology, Molecular Biology +17

Enhanced Antitumor Activity of Murine-Human Hybrid T-Cell Receptor (TCR) in Human Lymphocytes Is Associated with Improved Pairing and TCR/CD3 Stability

Cyrille J. Cohen, Yangbing Zhao, Zhili Zheng et al. · Cancer Research · 2006 · 467 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Selective elimination of leukemic CD34+ progenitor cells by cytotoxic T lymphocytes specific for WT1

Liquan Gao, Ilaria Bellantuono, Annika Elsässer et al. · Blood · 2000 · 408 citations

Medicine, Hematology, Oncology +11